Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/5/2012

engths of time or file additional lawsuits to defend its patent rights from challenges by companies that have submitted ANDAs for generic versions of OFIRMEV, and the substantial costs associated with such lawsuits; the potential introduction of generic competition to OFIRMEV in the event Cadence is unsuccessful in current or future patent litigation; Cadence's dependence on its licensors for the maintenance and enforcement of its intellectual property rights; the potential product liability exposure associated with pharmaceutical products such as OFIRMEV and other products Cadence may in-license or acquire; Cadence's ability to fully comply with numerous federal, state and local laws and regulatory requirements that apply to its commercial activities; public concern regarding the safety of drug products such as OFIRMEV, which could result in the implementation by regulatory agencies of new requirements to include unfavorable information in the labeling for OFIRMEV; the risk that Cadence may not be able to raise sufficient capital when needed, or at all; and other risks detailed under "Risk Factors" and elsewhere in Cadence's periodic reports and other filings made with the Securities and Exchange Commission from time to time. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995, and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Cadence® and OFIRMEV® are trademarks of Cadence Pharmaceuticals, Inc. Contact:

William R. LaRue

Kelli FranceSVP & Chief Financial Officer

Media RelationsCadence Pharmaceuticals, Inc.

WCGPhone: 858-436-1400

Phone:  415-946-1076 CADENCE PHARMACEUTICALS, INC.
CONDENSED STATEMENTS OF OPERATIONS
(unaudited)
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
3. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2012 Financial Results On November 5, 2012
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Calif. , July 7, 2015  Essentialis, a venture-backed ... agonists for the treatment of orphan neurobehavioral and metabolic diseases, ... and CSO, will present a corporate update at the Cantor ... Conference Date: Wednesday, July 8, 2015 Time: ... About Essentialis, Inc. ...
(Date:7/7/2015)... NEW YORK , July 7, 2015 ... new generation of drugs within human and veterinary oncology, ... the Securities and Exchange Commission, in connection with the ... the NASDAQ Stock Market. The number of American Depositary ... price range for the offering have not yet been ...
(Date:7/7/2015)... Ill. , July 7, 2015  Monopar Therapeutics ... oncology compounds, announced that its co-founder and CEO, ... British Council,s Education U.K. Alumni Entrepreneurial Award. The British ... China , India , and ... recognizes outstanding achievements made by entrepreneurs who have leveraged ...
Breaking Medicine Technology:Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... 2011 Scientists at Osel Inc . and ... a new way to prevent HIV infection by genetically ... block viral transmission. Bioengineered bacteria introduced into the vaginal ... of simian HIV (SHIV) by nearly two thirds. ...
... July 18, 2011 Data from high-risk patients requiring ... nondeferrable, non-cardiac surgery show good short- and long-term clinical ... according to a study published online on the journal ... In the single-center study, patients treated with the Genous ...
Cached Medicine Technology:Scientists Use Live Bacteria to Fight HIV 2Scientists Use Live Bacteria to Fight HIV 3OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 2OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 3
(Date:7/7/2015)... ... ... Difass USA, a modern supplement brand committed to excellence, understands that sometimes ... knowing that there is hopefully a vacation to look forward to this summer. But ... a vacation can be quite stressful, and it’s difficult sometimes to fully disconnect and ...
(Date:7/7/2015)... MA (PRWEB) , ... July 07, 2015 , ... The ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition ... and other men who have sex with men (MSM) and transgender women, the ...
(Date:7/7/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, recently ... community through company-wide volunteering efforts. , On an annual basis, in coordination with ... in need throughout Baltimore and Washington D.C. , This year, SC&H Group’s ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... the experience for its patient community using its IDF ePHR, an electronic personal ... primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, diagnoses, ...
(Date:7/7/2015)... ... 07, 2015 , ... FSAstore.com today announced the launch of its ... makes it simple to use, spend and manage HSA funds with innovative tools including ... , According to a report by Devenir , approximately 13.8 million Americans have ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... The Providence Service,Corporation (Nasdaq: PRSC ) today announced ... Convertible Senior Subordinated Notes due in,2014. RBC Capital ... The private placement was priced off today,s closing ... annum and are convertible into,Providence common shares at a ...
... -- Net loss narrows to $2.6 million - record performance,-- Domestic open-heart revenues of $6.7 million - ... 2006, ... over third quarter 2006 ... quarter ...
... premiums written increase 21% over the ... quarterly results., FARMINGTON, Conn., Nov. 6 Darwin Professional,Underwriters, Inc. ... financial results for the third quarter ended September 30,2007. Highlights include: ... million. Third quarter gross premiums written ...
... Businesses, LEHIGH VALLEY, Pa., Nov. 6 Air ... in advanced discussions over Wacker,s,purchase of Air Products, shareholdings ... Air Products Polymers (APP), including APP,s,vinyl acetate-ethylene activities. Air ... As for WPS, Wacker owns 80 percent and Air ...
... first annual HealthSaver,Caffeinated Cities Survey, commissioned by ... found that the most caffeinated city in ... Phoenix and Atlanta. (Photo: http://www.newscom.com/cgi-bin/prnh/20071106/NYTU175 ... are San Francisco/Oakland, followed,closely by Philadelphia, New ...
... Calif., Nov. 6 The scant,details of the health ... and Senate President pro Tem Don Perata provides some,potential ... would,guarantee a windfall for private health insurance companies out ... to the Foundation for,Taxpayer and Consumer Rights (FTCR)., ...
Cached Medicine News:Health News:Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes 2Health News:AtriCure Reports Third Quarter 2007 Financial Results 2Health News:AtriCure Reports Third Quarter 2007 Financial Results 3Health News:AtriCure Reports Third Quarter 2007 Financial Results 4Health News:AtriCure Reports Third Quarter 2007 Financial Results 5Health News:AtriCure Reports Third Quarter 2007 Financial Results 6Health News:AtriCure Reports Third Quarter 2007 Financial Results 7Health News:AtriCure Reports Third Quarter 2007 Financial Results 8Health News:AtriCure Reports Third Quarter 2007 Financial Results 9Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 7Health News:Air Products in Advanced Discussions With Wacker Over Polymers Business 2Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 2Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 3Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 4Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 5Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 6Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 7Health News:The Good, the Bad, and the Ugly of the Nunez/Perata Health Plan 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: